# Ibandronate

## Bonviva inj 3mg/3mL

| 藥物代碼 | IBONV |
| :--- | :--- |
| 適應症 | Treatment of osteoporosis in postmenopausal women. |
| 副作用 | Back pain, pain in extremity, infection, asthenia, allergic reaction; GI disturbances; hypercholesterolemia; myalgia, joint disorder; arthritis; headache, dizziness, vertigo, nerve root lesion; upper resp infection, bronchitis, pneumonia, pharyngitis; UTI.Cardiovascular: Hypertension \(5.3% to 7.3% \)Gastrointestinal: Abdominal pain \(5.1% to 7.8% \), Diarrhea \(2.4% to 6.8% \), Indigestion \(3.6% to 11.9% \), Nausea \(2.1% to 5.1% \)Musculoskeletal: Backache \(4.3% to 13.5% \)Neurologic: Headache \(2.6% to 6.5% \)Respiratory: Bronchitis \(2.1% to 10% \), Upper respiratory infection \(2% to 33.7% \) |
| 禁忌 | Uncorrected hypocalcaemia. Severe renal impairment. |
| 藥物保存方式 | N/A |
| 用法用量 | 3 mg IV every 3 months. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | No \(Limited\) Human Data - animal data suggest moderate risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IVP, IVPUSH |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選  【N/S】 可選 |
| IVP 用法建議 | IV over 15-30 seconds |
| IVD 用法建議 | N/A |
| 注意事項 | 1.不可與含鈣溶液或其他靜脈輸注藥物混合使用 2.以15-30秒的時間靜脈推注3mg藥物，使用時務必小心，「不可」將Bonviva注入動脈或靜脈旁側，否則可能造成組織傷害。 |

